This is a test blog post, to test the Zapier and email automation.
Omniscope showcased their new technology - converting everyday blood draw into immunotherapy response - on the floor at ASCO25
Their platform showed:
🔍 Real-time insight into immune-checkpoint inhibitor (ICI) activity—no repeat biopsies required
🆕 Detection of treatment-related T-cell clones (new and pre-existing) that predict response
📈 71 % clonotype overlap between blood and tumor, confirming liquid biopsy as a powerful precision-oncology tool
🧭 T-cell state mapping throughout the course of treatment, spotlighting resistance mechanisms early